Dr. Stamatios Lerakis, MD
What this data tells you about Dr. Lerakis
Dr. Stamatios Lerakis is a cardiovascular disease specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lerakis performed 3,894 Medicare services across 2,864 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lerakis received a total of $24,988 from 11 pharmaceutical and/or device companies across 121 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lerakis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
2,013 | $7 | $40 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
481 | $181 | $930 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
378 | $36 | $78 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
172 | $3 | $10 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
137 | $22 | $100 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
135 | $6 | $30 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
108 | $18 | $90 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
108 | $12 | $60 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
63 | $94 | $470 |
| Heart muscle strain imaging | 61 | $10 | $107 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
56 | $66 | $310 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
53 | $15 | $70 |
| Transesophageal echocardiogram during heart surgery An ultrasound of the heart performed using a probe inserted into the esophagus while surgery on the heart or major blood vessels is taking place, including a written report. |
52 | $201 | $900 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. The procedure uses special cameras to create images of the heart's function. |
41 | $54 | $260 |
| 3D ultrasound of heart for congenital heart defects This procedure uses three-dimensional ultrasound imaging to evaluate the structure of the heart during an assessment for congenital heart defects. |
36 | $21 | $155 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
All-time payments by company (2019-2024) ›
Associated products mentioned in payments ›
The majority of payments (51%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lerakis is a cardiac & cardiac specialist, with above-average Medicare volume (top 21% in NY), with speaking/promotional industry engagement in the top 12% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lerakis experienced with ekg interpretation and report?
Does Dr. Lerakis receive payments from pharmaceutical companies?
How do Dr. Lerakis's costs compare to other cardiologists in New York?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology